Organogenesis Holdings Inc.(ORGO)

$2.55▲0.12 (4.94%)

Chart

Organogenesis Holdings Inc.(ORGO)

NASDAQ

$2.55▲0.12 (4.94%)

Chart Studio

ORGO(ORGO)

ORGO

Overview Intelligence Chart Historical Prices Fundamentals Key Metrics Earnings Growth Analysts News Financials Insiders Institutional

ORGO 49 articles

Organogenesis Q1 Earnings Call Highlights

marketbeat.com·May 8

Organogenesis Holdings Inc. (ORGO) Q1 2026 Earnings Call Transcript

seekingalpha.com·May 8

Organogenesis Holdings Inc. Reports First Quarter 2026 Financial Results

globenewswire.com·May 7

Organogenesis Completes Rolling Submission of Biologics License Application for ReNu®

globenewswire.com·Apr 28

What's Going On With Organogenesis Stock On Wednesday?

benzinga.com·Apr 8

Organogenesis: Clinical Win De-Risks 2026, Recovery In Sight

seekingalpha.com·Apr 7

Organogenesis Stock Rockets After Diabetic Foot Ulcer Trial Posts Statistically Significant Win

benzinga.com·Apr 7

Organogenesis Achieves Primary Endpoint in Randomized Controlled Trial of PuraPly®AM

globenewswire.com·Apr 6

Organogenesis Announces Successful FDA Meeting and Plan to File BLA for ReNu® for Knee Osteoarthritis Pain

globenewswire.com·Apr 6

Organogenesis Holdings Inc. to Report First Quarter of Fiscal Year 2026 Financial Results on May 7, 2026

globenewswire.com·Apr 6

SG Americas Securities LLC Acquires 376,623 Shares of Organogenesis $ORGO

defenseworld.net·Apr 4

Organogenesis Holdings Inc. (ORGO) Q4 2025 Earnings Call Transcript

seekingalpha.com·Feb 26

Organogenesis Holdings Inc. Reports Fourth Quarter 2025 Financial Results, Posts Record Revenue

globenewswire.com·Feb 26

Organogenesis Holdings Inc. to Report Fourth Quarter and Fiscal Year 2025 Financial Results on February 26, 2026

globenewswire.com·Feb 19

INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Organogenesis Holdings Inc. - ORGO

globenewswire.com·Feb 3

INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Organogenesis Holdings Inc. - ORGO

prnewswire.com·Jan 29

INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Organogenesis Holdings Inc. - ORGO

prnewswire.com·Jan 22

INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Organogenesis Holdings Inc. - ORGO

globenewswire.com·Jan 20

INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Organogenesis Holdings Inc. - ORGO

prnewswire.com·Jan 15

INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Organogenesis Holdings Inc. - ORGO

globenewswire.com·Jan 13

INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Organogenesis Holdings Inc. - ORGO

prnewswire.com·Jan 8

INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Organogenesis Holdings Inc. - ORGO

globenewswire.com·Jan 6

Organogenesis (NASDAQ:ORGO) Trading Down 5% – Time to Sell?

defenseworld.net·Jan 4

INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Organogenesis Holdings Inc. - ORGO

globenewswire.com·Dec 30

Contrasting Organogenesis (NASDAQ:ORGO) & Catalyst Pharmaceuticals (NASDAQ:CPRX)

defenseworld.net·Dec 28

Organogenesis Announces Initiation of Biologics License Application for ReNu®

globenewswire.com·Dec 23

Assenagon Asset Management S.A. Has $20.49 Million Stock Position in Organogenesis $ORGO

defenseworld.net·Dec 20

Organogenesis Announces Successful FDA Meeting and Plan to File BLA for ReNu® for Knee Osteoarthritis Pain

globenewswire.com·Dec 15

Organogenesis: High-Tech Skin Substitute Company On Sale

seekingalpha.com·Dec 11

Organogenesis Holdings Inc. (ORGO) Q3 2025 Earnings Call Transcript

seekingalpha.com·Nov 7

Organogenesis Holdings Inc. Reports Third Quarter 2025 Financial Results, Posts Record Revenue and Raises 2025 Guidance

globenewswire.com·Nov 6

Organogenesis Applauds CMS's Significant Step In Payment Reform

globenewswire.com·Nov 3

Organogenesis Holdings Inc. Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

globenewswire.com·Oct 31

Cwm LLC Sells 18,000 Shares of Organogenesis $ORGO

defenseworld.net·Oct 30

INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Organogenesis Holdings Inc. - ORGO

prnewswire.com·Oct 28

INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Organogenesis Holdings Inc. - ORGO

prnewswire.com·Oct 23

INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Organogenesis Holdings Inc. - ORGO

prnewswire.com·Oct 18

Organogenesis Holdings Inc. Investigated for Securities Fraud Violations - Contact the DJS Law Group to Discuss Your Rights – ORGO

businesswire.com·Oct 17

INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Organogenesis Holdings Inc. - ORGO

prnewswire.com·Oct 13

INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Organogenesis Holdings Inc. - ORGO

prnewswire.com·Oct 8

Organogenesis Holdings Inc. to Report Third Quarter of Fiscal Year 2025 Financial Results on November 6, 2025

globenewswire.com·Oct 1

Organogenesis: Mixed ReNu Data, But Policy Tailwinds And Growth Remain Bullish

seekingalpha.com·Sep 29

Why Is Organogenesis Stock Trading Lower Friday?

benzinga.com·Sep 26

Organogenesis Provides Update on Second Phase 3 ReNu® Study

globenewswire.com·Sep 25

Organogenesis Holdings Inc. to Participate in Upcoming Investor Conferences in September

globenewswire.com·Aug 27

Organogenesis Holdings Inc. (ORGO) Q2 2025 Earnings Call Transcript

seekingalpha.com·Aug 8

ORGO Sales Drop 23%

fool.com·Aug 7

Organogenesis Holdings Inc. Reports Second Quarter 2025 Financial Results

globenewswire.com·Aug 7

Organogenesis Holdings Inc. to Report Second Quarter of Fiscal Year 2025 Financial Results on August 7, 2025

globenewswire.com·Jul 22

Explore More

S&P 500 Screener

Filter and sort all 500 stocks

Market Movers

Today's biggest gainers and losers

Market Heatmap

Visual sector performance